- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Adult Malignant Peripheral Nerve Sheath Tumor
Total 2328 results
-
Ludwig Institute for Cancer ResearchTerminated
-
4SC AGCompletedMalignant MelanomaGermany, Italy
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia, Brazil, Spain, South Africa, Ukraine, Bosnia and Herzegovina
-
Ultimovacs ASAOslo University HospitalActive, not recruiting
-
University of Kansas Medical CenterCompletedMalignant MelanomaUnited States
-
University of BaselUniversity Hospital, Basel, SwitzerlandCompletedMalignant Melanoma
-
CelgenePrologue Research InternationalCompleted
-
Eli Lilly and CompanyCompletedMalignant MelanomaUnited States
-
Milton S. Hershey Medical CenterCompletedMalignant MelanomaUnited States
-
Skin Analytics LimitedCompleted
-
University of ArizonaTerminatedMalignant MelanomaUnited States
-
Henan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.UnknownMalignant MelanomaChina
-
Hoffmann-La RocheCompletedMalignant MelanomaCanada, Spain, United Kingdom, Hungary, Australia, Austria, Belgium, Ecuador, Estonia, Finland, Ireland, Italy, Korea, Republic of, Mexico, Netherlands, Portugal, Slovenia, Sweden, Turkey, Brazil, India, Germany, Bosnia and Herzegovina and more
-
Bristol-Myers SquibbNo longer availableMalignant MelanomaUnited States, Canada
-
Hoffmann-La RocheCompleted
-
University of California, DavisCompletedMelanoma | Malignant MelanomaUnited States
-
AstraZenecaCompletedMelanoma | Malignant MelanomaUnited Kingdom, Netherlands
-
University Hospital TuebingenGerman Research FoundationCompleted
-
AstraZenecaCompleted
-
Cytos Biotechnology AGCompletedMalignant MelanomaSwitzerland
-
Bristol-Myers SquibbCompletedMalignant MelanomaUnited States
-
SentoClone ABUnknownMalignant MelanomaSweden
-
Royal Marsden NHS Foundation TrustUnknown
-
University Hospital TuebingenCompletedMalignant MelanomaGermany
-
Cytos Biotechnology AGCompletedMalignant MelanomaSwitzerland
-
NYU Langone HealthNovartis Pharmaceuticals; The Children's Tumor FoundationCompletedNeurofibromatosis Type IIUnited States
-
Manchester University NHS Foundation TrustCompletedNeurofibromatosis Type 2United Kingdom
-
PTC TherapeuticsUnited States Department of DefenseTerminated
-
Centre Hospitalier Universitaire de NiceUnknownNeurofibromatosis 2 | Dermatology/Skin - OtherFrance
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Massachusetts General HospitalThe Children's Tumor FoundationCompletedNeurofibromatosis | Neurofibromatosis 2 | Schwannomatosis | Neurofibromatosis IUnited States
-
Hongmeng YuRecruitingOlfactory NeuroblastomaChina
-
Nicklaus Children's Hospital f/k/a Miami Children...TerminatedRecurrent Childhood Medulloblastoma | Recurrent Childhood Ependymoma | Childhood Atypical Teratoid/Rhabdoid Tumor | Embryonal Tumor With Abundant Neuropil and True Rosettes | Metastatic Malignant Neoplasm to the LeptomeningesUnited States
-
Markus JoergerRecruiting
-
Assistance Publique - Hôpitaux de ParisNational Cancer Institute (NCI)Recruiting
-
Reata, a wholly owned subsidiary of BiogenWithdrawn
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)TerminatedMelanoma | Malignant Melanoma
-
Hoffmann-La RocheCompletedA Pharmacokinetic and Metabolism Study of 14C-labeled RO5185426 on Patients With Metastatic MelanomaMalignant MelanomaSwitzerland
-
Oslo University HospitalActive, not recruitingMalignant MelanomaNorway
-
Ultimovacs ASAActive, not recruitingMalignant MelanomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedMalignant MelanomaUnited States
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Spain, Hungary, Israel, United Kingdom, Australia, Austria, Belgium, Czechia, France, Germany, Italy, Netherlands, Russian Federation, Sweden, Switzerland, Canada, New Zealand, Norway
-
Bristol-Myers SquibbMedarex; Ono Pharma USA IncCompleted
-
Medical University of GrazCompleted
-
Prof. Dr. med. Dirk SchadendorfTerminatedMalignant MelanomaGermany
-
Immunocore LtdTerminated
-
Genentech, Inc.Completed
-
Immunocore LtdCompletedMalignant MelanomaUnited Kingdom, United States
-
CelgeneUniversity of ArizonaCompletedMalignant MelanomaCanada, United States, Australia, United Kingdom, France, Italy, Spain, Germany, Netherlands